Helmholtz Munich seeks to further the prevention and therapy of diabetes mellitus and obesity—with a particular focus on precision medicine.

Diabetes research at Helmholtz Munich centers on type 1, type 2 and gestational diabetes and their causes as well as metabolic and immunological disorders. Other focal points are the development and regeneration of insulin-producing beta cells of the pancreas. Basic research and clinical research are intertwined in close interdisciplinary cooperation with the Munich universities.

Experimental Genetics 

• Prof. Dr. Martin Hrabě de Angelis
• Prof. Dr. Johannes Beckers
• Dr. Raffaele Teperino 

Type 1 Diabetes Research

• Prof. Dr. Anette-Gabriele Ziegler, Prof. Dr. Peter Achenbach 
• Type 1 Diabetes Immunology 
• Prof. Dr. Carolin Daniel 

Diabetes and Obesity

• Prof. Dr. Timo Müller 

Adipocytes and Metabolism 

• Dr. Siegfried Ussar 

Diabetes and Cancer 

• Prof. Dr. Stephan Herzig 

Diabetes and Endocrinology 

• Prof. Dr. Nina-Henriette Uhlenhaut 

Diabetes and Regeneration Research 

• Prof. Dr. Heiko Lickert 

Translational Stem Cell Research

• Prof. Dr. Henrik Semb 

Diabetes and Organoid Technology

• Prof. Dr. Matthias Hebrock 

Epidemiology

• Prof. Dr. Annette Peters 

Computational Biology 

• Prof. Dr. Dr. Fabian Theis,  
• Dr. Michael Menden (DZD Core Unit Computational Biomedicine) 

Clinical Cooperation Group Nutrigenomics and Type 2 Diabetes Mellitus, TUM 

• Prof. Dr. Hans Hauner 

Clinical Cooperation Group Prediction and Sub-Classification of Type 2 Diabetes Mellitus, LMU 

• Prof. Dr. Jochen Seissler